3FY0
Crystal structure of PAK1 kinase domain with ruthenium complex DW1
3FY0 の概要
| エントリーDOI | 10.2210/pdb3fy0/pdb |
| 関連するPDBエントリー | 3FXZ |
| 分子名称 | Serine/threonine-protein kinase PAK 1, Ruthenium pyridocarbazole (3 entities in total) |
| 機能のキーワード | transferase, kinase, atp-binding, phosphorylation, allosteric enzyme, apoptosis, cell junction, nucleotide-binding, phosphoprotein, serine/threonine-protein kinase |
| 由来する生物種 | Homo sapiens (human) |
| 細胞内の位置 | Cytoplasm : Q13153 |
| タンパク質・核酸の鎖数 | 1 |
| 化学式量合計 | 33863.68 |
| 構造登録者 | |
| 主引用文献 | Maksimoska, J.,Feng, L.,Harms, K.,Yi, C.,Kissil, J.,Marmorstein, R.,Meggers, E. Targeting Large Kinase Active Site with Rigid, Bulky Octahedral Ruthenium Complexes J.Am.Chem.Soc., 130:15764-15765, 2008 Cited by PubMed Abstract: A strategy for targeting protein kinases with large ATP-binding sites by using bulky and rigid octahedral ruthenium complexes as structural scaffolds is presented. A highly potent and selective GSK3 and Pim1 half-sandwich complex NP309 was successfully converted into a PAK1 inhibitor by making use of the large octahedral compounds Lambda-FL172 and Lambda-FL411 in which the cyclopentadienyl moiety of NP309 is replaced by a chloride and sterically demanding diimine ligands. A 1.65 A cocrystal structure of PAK1 with Lambda-FL172 reveals how the large coordination sphere of the ruthenium complex matches the size of the active site and serves as a yardstick to discriminate between otherwise closely related binding sites. PubMed: 18973295主引用文献が同じPDBエントリー |
| 実験手法 | X-RAY DIFFRACTION (2.35 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






